These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33241379)

  • 21. Cytokines play a central role in the pathogenesis of systemic lupus erythematosus.
    Singh AK
    Med Hypotheses; 1992 Dec; 39(4):356-9. PubMed ID: 1494323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy.
    Summers SA; Hoi A; Steinmetz OM; O'Sullivan KM; Ooi JD; Odobasic D; Akira S; Kitching AR; Holdsworth SR
    J Autoimmun; 2010 Dec; 35(4):291-8. PubMed ID: 20810248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased lipid and protein oxidation and lowered anti-oxidant defenses in systemic lupus erythematosus are associated with severity of illness, autoimmunity, increased adhesion molecules, and Th1 and Th17 immune shift.
    Scavuzzi BM; Simão ANC; Iriyoda TMV; Lozovoy MAB; Stadtlober NP; Franchi Santos LFDR; Flauzino T; de Medeiros FA; de Sá MC; Consentin L; Reiche EMV; Maes M; Dichi I
    Immunol Res; 2018 Feb; 66(1):158-171. PubMed ID: 29185130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin D in systemic lupus erythematosus.
    Kamen D; Aranow C
    Curr Opin Rheumatol; 2008 Sep; 20(5):532-7. PubMed ID: 18698173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity.
    Baccala R; Hoebe K; Kono DH; Beutler B; Theofilopoulos AN
    Nat Med; 2007 May; 13(5):543-51. PubMed ID: 17479100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apoptosis in systemic lupus erythematosus.
    White S; Rosen A
    Curr Opin Rheumatol; 2003 Sep; 15(5):557-62. PubMed ID: 12960480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Focusing on tissue biomarkers. Estrogens as key players in the immune response and autoimmunity].
    Vásárhelyi B; Mészáros K; Karvaly G; Patócs A
    Orv Hetil; 2015 Dec; 156(51):2070-6. PubMed ID: 26654543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired suppressive capacity of activation-induced regulatory B cells in systemic lupus erythematosus.
    Gao N; Dresel J; Eckstein V; Gellert R; Störch H; Venigalla RK; Schwenger V; Max R; Blank N; Lorenz HM; Tretter T
    Arthritis Rheumatol; 2014 Oct; 66(10):2849-61. PubMed ID: 24942956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxidative stress in systemic lupus erythematosus: relationship to Th1 cytokine and disease activity.
    Shah D; Kiran R; Wanchu A; Bhatnagar A
    Immunol Lett; 2010 Mar; 129(1):7-12. PubMed ID: 20105444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extracellular Vesicles as Biomarkers of Systemic Lupus Erythematosus.
    Perez-Hernandez J; Cortes R
    Dis Markers; 2015; 2015():613536. PubMed ID: 26435565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identifying Crosstalk between Raf Kinase Inhibitor Protein and Systemic Lupus Erythematosus.
    Navasardyan I; Bonavida B
    Crit Rev Immunol; 2019; 39(6):423-437. PubMed ID: 32421956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New insights into the pathogenesis of systemic lupus erythematosus (SLE): the role of apoptosis.
    Bijl M; Limburg PC; Kallenberg CG
    Neth J Med; 2001 Aug; 59(2):66-75. PubMed ID: 11476915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factor B activation in systemic lupus erythematosus.
    Segurado OG; Gomez-Reino J; Arnaiz-Villena A
    Arthritis Rheum; 1990 Oct; 33(10):1598-9. PubMed ID: 2222545
    [No Abstract]   [Full Text] [Related]  

  • 34. Sleep disorders and systemic lupus erythematosus.
    Palagini L; Tani C; Mauri M; Carli L; Vagnani S; Bombardieri S; Gemignani A; Mosca M
    Lupus; 2014 Feb; 23(2):115-23. PubMed ID: 24421291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity.
    Theofilopoulos AN; Koundouris S; Kono DH; Lawson BR
    Arthritis Res; 2001; 3(3):136-41. PubMed ID: 11299053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant cytokine gene expression in the hippocampus in murine systemic lupus erythematosus.
    Tomita M; Holman BJ; Santoro TJ
    Neurosci Lett; 2001 Apr; 302(2-3):129-32. PubMed ID: 11290404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of poor sleep quality in patients with systemic lupus erythematosus.
    Inoue M; Shiozawa K; Yoshihara R; Yamane T; Shima Y; Hirano T; Makimoto K
    Clin Rheumatol; 2017 May; 36(5):1053-1062. PubMed ID: 28138857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytokines and anxiety in systemic lupus erythematosus (SLE) patients not receiving antidepressant medication: a little-explored frontier and some of its brief history.
    Figueiredo-Braga M; Mota-Garcia F; O'Connor JE; Garcia JR; Mota-Cardoso R; Cardoso CS; de Sousa M
    Ann N Y Acad Sci; 2009 Sep; 1173():286-91. PubMed ID: 19758164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Th1, Th2, and Th17 cytokines in systemic lupus erythematosus.
    Muhammad Yusoff F; Wong KK; Mohd Redzwan N
    Autoimmunity; 2020 Feb; 53(1):8-20. PubMed ID: 31771364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AhR-ROR-γt complex is a therapeutic target for MAP4K3/GLK
    Chuang HC; Chen YM; Chen MH; Hung WT; Yang HY; Tseng YH; Tan TH
    FASEB J; 2019 Oct; 33(10):11469-11480. PubMed ID: 31318609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.